The Catalyst - A PhRMA Blog | Patent Protections

Stay Connected
Events
Press Room
Members Site
Our Network

About
Advocacy
Science
Patients
Resources
Blog

About
Advocacy
Science
Patients
Resources
Blog
Stay Connected
Events
Pressroom
Members
Our Network

Search the PhRMA Network

X

Stay Connected

Sign Up for Updates

Welcome to the future of medicine. Where together, we go boldly.

PPA strives to improve patient health, advance medical innovation and fuel economic growth.

The PhRMA Foundation supports the research and career endeavors of scientists in drug discovery and development.

Access Better Coverage educates consumers about the ABCs of health coverage and access to medicines.

PhRMA_ABC_Stacked_Pure_White

Learn more about America's biopharmaceutical companies and how they seek to improve patients' lives.

We Work For Health aims to increase awareness by uniting workers throughout the industry.

Patent protection should always be considered by an inventor during the initial stages of their invention.

Working to spread awareness and education about the importance of secure drug disposal.

Many Americans are struggling to afford their medicines and have important questions about their medicine costs. Let's Talk About Cost addresses these questions.

There are a lot of conversations in Washington about how to change Medicare Part D, but they aren't always focused on what seniors care about most: affordability and predictability.

About

PhRMA represents the country’s leading biopharmaceutical research companies and supports the search for new treatments and cures.

Industry Profile 2016

Policy Solutions

Advocacy

From accessing medicines to intellectual property to drug safety, PhRMA is devoted to advancing public policies that support innovative medical research, improve treatments and yield real results.

Policy Solutions

Science

Today, cutting-edge medical science is transforming patients’ lives. Discover how scientists and researchers are advancing science.

The 20-year journey yielding a new weapon against cancer

Stopping the Spread of Ebola

Patients

Patient support and assistance is the top priority for PhRMA’s member companies, who are working hard to improve patients’ lives through the discovery and development of new medicines and treatments.

Share the Savings

Patient-Focused Drug Development

Resources

Explore the Resource Library, the interactive State Map and the Chart Pack reports.

Clinical Trials

We are creating a place where we can share ideas, provide the perspective of America's biopharmaceutical companies and, most importantly, listen to you.

IP Explained: What is Section 101 and why reforms are needed

By Tom Wilbur | June 26, 2019

In today’s IP Explained post, we’re taking a closer look at Section 101 of the United States Patent Act and how proposed reforms could both level the playing field for innovators across all... Read More

Fact Check Friday: The truth about biopharmaceutical patents

By Mark Grayson | August 26, 2016

MYTH: Biopharmaceutical companies use government-protected monopolies to raise costs on medicines. FACT: Patent-protected medicines routinely face competition from other brand name medicines,... Read More

Search the Catalyst

View Posts by Topic

see all

View Posts by Contributor

View Posts by Date

see all

View posts by Series

Ask about Adherence (32)
Medicare Monday (100)
340B Spotlight (42)
Cost & Consequence (0)

Subscribe to Email Updates

Most Popular Posts

Most Popular Posts

Members Site
Contact PhRMA
Privacy Policy
Terms of Service
Site Map

Pharmaceutical Research and Manufacturers of America®
950 F Street, NW Suite 300, Washington, DC 20004